If an event is taking place for the second time and has to put up a waiting list for participants, you can truly call it a big success. 550 participants mainly from coordinating centers for clinical studies (Koordinierungszentren für Klinische Studien), hospitals, study sites, but also from industry were lucky to attend the conference with 22 exhibitors. The comprehensive program offered covered various aspects ranging from updates on the new EU clinical trial regulation, audits at study sites, the new GDPR and big data. One hot topic was the impact of globalization on clinical trials. Fadja Ehlail, com-across, outlined various points that one comes across when including people from other cultures in clinical trials. Which cultural aspects have to be taken into account so that people don’t drop out? Making sure to integrate the whole family e.g. is one thing that is important when working with patients for example with Arabian background. The discussion that followed the keynote was very interactive and showed the importance of this topic in the DACH countries.
Another talk that delivered very hands-on information was given by Kornelia Giersig, University Hospitals Tirol, about the dangerous goods regulations (IATA-DGR, ADR). Getting biological samples from study sites to the central laboratory might sound easy on the first view, but has to follow very strict regulations.
All talks were focused on giving very practical information to the people working on clinical trials and therefore very worthwhile.
Exhibiting at the conference was great way for MLM to get in contact with the staff actually working with our kits at the sites and getting their valuable feedback.
Congratulations to the organizers for setting up a great event like that!